GB201816399D0 - Cell - Google Patents
CellInfo
- Publication number
- GB201816399D0 GB201816399D0 GBGB1816399.8A GB201816399A GB201816399D0 GB 201816399 D0 GB201816399 D0 GB 201816399D0 GB 201816399 A GB201816399 A GB 201816399A GB 201816399 D0 GB201816399 D0 GB 201816399D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/463—Cellular immunotherapy characterised by recombinant expression
- A61K39/4631—Chimeric Antigen Receptors [CAR]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464469—Tumor associated carbohydrates
- A61K39/464471—Gangliosides, e.g. GM2, GD2 or GD3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70521—CD28, CD152
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/515—CD3, T-cell receptor complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1816399.8A GB201816399D0 (en) | 2018-10-08 | 2018-10-08 | Cell |
PCT/GB2019/052829 WO2020074868A1 (en) | 2018-10-08 | 2019-10-07 | Cell |
EP19791327.0A EP3864034A1 (en) | 2018-10-08 | 2019-10-07 | Cell |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1816399.8A GB201816399D0 (en) | 2018-10-08 | 2018-10-08 | Cell |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201816399D0 true GB201816399D0 (en) | 2018-11-28 |
Family
ID=64397609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1816399.8A Ceased GB201816399D0 (en) | 2018-10-08 | 2018-10-08 | Cell |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3864034A1 (en) |
GB (1) | GB201816399D0 (en) |
WO (1) | WO2020074868A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115181751A (en) * | 2021-04-02 | 2022-10-14 | 苏州博腾生物制药有限公司 | Chimeric antigen receptors targeting albumin and methods of use thereof |
-
2018
- 2018-10-08 GB GBGB1816399.8A patent/GB201816399D0/en not_active Ceased
-
2019
- 2019-10-07 EP EP19791327.0A patent/EP3864034A1/en not_active Withdrawn
- 2019-10-07 WO PCT/GB2019/052829 patent/WO2020074868A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3864034A1 (en) | 2021-08-18 |
WO2020074868A1 (en) | 2020-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201813178D0 (en) | Cell | |
GB2577114B (en) | Battery | |
IL273915A (en) | Cell | |
GB201901307D0 (en) | Electrolytes | |
GB201803079D0 (en) | Cell | |
PL3654417T3 (en) | Battery | |
GB201707783D0 (en) | Cell | |
GB201707779D0 (en) | Cell | |
GB201713078D0 (en) | T Cell Modification | |
GB2577261B (en) | Battery | |
GB201720949D0 (en) | Cell | |
GB201819540D0 (en) | T cell modification | |
GB201718697D0 (en) | Cell | |
GB201904971D0 (en) | Cell | |
GB201815190D0 (en) | Battery compartent | |
GB201906202D0 (en) | Cell | |
GB201807693D0 (en) | Cell | |
GB201818625D0 (en) | Battery | |
EP4048783C0 (en) | Modified cell | |
GB201816399D0 (en) | Cell | |
GB201805918D0 (en) | Cell | |
CA201678S (en) | Battery | |
GB201804917D0 (en) | Battery | |
GB201714718D0 (en) | Cell | |
GB2577995B (en) | Cell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |